DAXOR'S INNOVATIVE BVA-100 BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24

GlobeNewswire10/09 20:00

Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Yahoo Finance10/08 20:00

Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device

GlobeNewswire09/28 05:00

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024

GlobeNewswire09/19 20:00

Daxor Announces Review Published In Cardiorenal Medicine Highlighting The Role Of Blood Volume Analysis In Enhancing Care And Outcomes For Cardiorenal Syndrome; BVA Improves Precision In Diuretic And Red Cell Therapies For Personalized Treatment

Benzinga09/12 20:02

Newly Published Review Highlights the Pivotal Role of Daxor's Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management

Yahoo Finance09/12 20:00